Skip to menu Skip to content Skip to footer

2023

Journal Article

In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates

Burke, Andrew, Carter, Robyn, Tolson, Carla, Congdon, Jacob, Duplancic, Christine, Bursle, Evan, Bell, Scott C., Roberts, Jason A. and Thomson, Rachel (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates. International Journal of Antimicrobial Agents, 62 (4) 106938, 1-6. doi: 10.1016/j.ijantimicag.2023.106938

In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates

2023

Journal Article

Peri-operative pharmacokinetics of cefazolin prophylaxis during valve replacement surgery

Alli, Ahmad, Paruk, Fathima, Roger, Claire, Lipman, Jeffrey, Calleemalay, Daren, Wallis, Steven C., Scribante, Juan, Richards, Guy A. and Roberts, Jason A. (2023). Peri-operative pharmacokinetics of cefazolin prophylaxis during valve replacement surgery. PLoS One, 18 (9) e0291425, 1-14. doi: 10.1371/journal.pone.0291425

Peri-operative pharmacokinetics of cefazolin prophylaxis during valve replacement surgery

2023

Journal Article

An in vitro dynamic bioreactor model for evaluating antimicrobial effectiveness on periodontal polymicrobial biofilms: a proof-of-concept study

Ramachandra, Srinivas Sulugodu, Sime, Fekade Bruck, Naicker, Saiyuri, Han, Pingping, Lee, Ryan S.B., Wallis, Steven C., Roberts, Jason A. and Ivanovski, Sašo (2023). An in vitro dynamic bioreactor model for evaluating antimicrobial effectiveness on periodontal polymicrobial biofilms: a proof-of-concept study. Journal of Periodontology, 95 (4), 384-396. doi: 10.1002/JPER.23-0086

An in vitro dynamic bioreactor model for evaluating antimicrobial effectiveness on periodontal polymicrobial biofilms: a proof-of-concept study

2023

Journal Article

Why is the implementation of beta-lactam therapeutic drug monitoring for the critically ill falling short? A multicenter mixed-methods study

Barreto, Erin F., Chitre, Pooja N., Pine, Kathleen H., Shepel, Kathryn K., Rule, Andrew D., Alshaer, Mohammad H., Abdul Aziz, Mohd Hafiz, Roberts, Jason A., Scheetz, Marc H., Ausman, Sara E., Moreland-Head, Lindsay N., Rivera, Christina G., Jannetto, Paul J., Mara, Kristin C. and Boehmer, Kasey R. (2023). Why is the implementation of beta-lactam therapeutic drug monitoring for the critically ill falling short? A multicenter mixed-methods study. Therapeutic Drug Monitoring, 45 (4), 508-518. doi: 10.1097/FTD.0000000000001059

Why is the implementation of beta-lactam therapeutic drug monitoring for the critically ill falling short? A multicenter mixed-methods study

2023

Journal Article

Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients—a population pharmacokinetic study

Tsai, Danny, Zam, Betty B., Tongs, Carleigh, Chiong, Fabian, Sajiv, Cherian, Pawar, Basant, Ashok, Aadith, Cooper, Brynley P, Tong, Steven Y C, Janson, Sonja, Wallis, Steven C., Roberts, Jason A. and Parker, Suzanne L. (2023). Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients—a population pharmacokinetic study. Journal of Antimicrobial Chemotherapy, 78 (8), 1963-1973. doi: 10.1093/jac/dkad190

Validating a novel three-times-weekly post-hemodialysis ceftriaxone regimen in infected Indigenous Australian patients—a population pharmacokinetic study

2023

Journal Article

International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary

Hong, Lisa T., Downes, Kevin J., FakhriRavari, Alireza, Abdul‐Mutakabbir, Jacinda C., Kuti, Joseph L., Jorgensen, Sarah, Young, David C., Alshaer, Mohammad H., Bassetti, Matteo, Bonomo, Robert A., Gilchrist, Mark, Jang, Soo Min, Lodise, Thomas, Roberts, Jason A., Tängdén, Thomas, Zuppa, Athena and Scheetz, Marc H. (2023). International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 43 (8), 736-739. doi: 10.1002/phar.2844

International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary

2023

Journal Article

International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists

Hong, Lisa T., Downes, Kevin J., FakhriRavari, Alireza, Abdul‐Mutakabbir, Jacinda C., Kuti, Joseph L., Jorgensen, Sarah, Young, David C., Alshaer, Mohammad H., Bassetti, Matteo, Bonomo, Robert A., Gilchrist, Mark, Jang, Soo Min, Lodise, Thomas, Roberts, Jason A., Tängdén, Thomas, Zuppa, Athena and Scheetz, Marc H. (2023). International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 43 (8), 740-777. doi: 10.1002/phar.2842

International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists

2023

Journal Article

Optimal drug therapy for Staphylococcus aureus bacteraemia in adults

Legg, Amy, Davis, Joshua S. and Roberts, Jason A. (2023). Optimal drug therapy for Staphylococcus aureus bacteraemia in adults. Current Opinion in Critical Care, 29 (5), 446-456. doi: 10.1097/mcc.0000000000001072

Optimal drug therapy for Staphylococcus aureus bacteraemia in adults

2023

Journal Article

Longer term mortality and kidney outcomes of participants in the Combination Antibiotics for Methicillin Resistant Staphylococcus aureus (CAMERA2) trial: a post-hoc analysis

Legg, Amy, Roberts, Matthew A., Davies, Jane, Cass, Alan, Meagher, Niamh, Sud, Archana, Daitch, Vered, Dishon-Benattar, Yael, Yahav, Dafna, Paul, Mical, Xinxin, Chen, He Ping, Yeo, Lye, David, Lee, Russel, Robinson, J Owen, Foo, Hong, Tramontana, Adrian R., Bak, Narin, Grenfell, Adelaide, Rogers, Benjamin, Li, Ying, Joshi, Neela, O’Sullivan, Matthew, McKew, Genevieve, Ghosh, Niladri, Schneider, Kellie, Holmes, Natasha E., Dotel, Ravindra, Chia, Timothy ... Combination Antibiotics for Methicillin-Resistant Staphylococcus aureus (CAMERA2) Study Group (2023). Longer term mortality and kidney outcomes of participants in the Combination Antibiotics for Methicillin Resistant Staphylococcus aureus (CAMERA2) trial: a post-hoc analysis. Open Forum Infectious Diseases, 10 (7) ofad337, 1. doi: 10.1093/ofid/ofad337

Longer term mortality and kidney outcomes of participants in the Combination Antibiotics for Methicillin Resistant Staphylococcus aureus (CAMERA2) trial: a post-hoc analysis

2023

Journal Article

International survey of antibiotic dosing and monitoring in adult intensive care units

Williams, Paul G., Tabah, Alexis, Cotta, Menino Osbert, Sandaradura, Indy, Kanji, Salmaan, Scheetz, Marc H., Imani, Sahand, Elhadi, Muhammed, Luque-Pardos, Sònia, Schellack, Natalie, Sanches, Cristina, Timsit, Jean-Francois, Xie, Jiao, Farkas, Andras, Wilks, Kathryn, Roberts, Jason A., Brinkmann, Alexander, Ramanan, Mahesh, Koulenti, Despoina, Gurjar, Mohan, Sulaiman, Helmi, Shrestha, Gentle, Cortegiani, Andrea, Crespo, Monica, Ling, Lowell, Abidi, Khalid and Schellongowski, Peter (2023). International survey of antibiotic dosing and monitoring in adult intensive care units. Critical Care, 27 (1) 241, 1-11. doi: 10.1186/s13054-023-04527-1

International survey of antibiotic dosing and monitoring in adult intensive care units

2023

Journal Article

Antifungal dosing in critically ill patients on extracorporeal membrane oxygenation

Lyster, Haifa, Shekar, Kiran, Watt, Kevin, Reed, Anna, Roberts, Jason A. and Abdul-Aziz, Mohd-Hafiz (2023). Antifungal dosing in critically ill patients on extracorporeal membrane oxygenation. Clinical Pharmacokinetics, 62 (7), 931-942. doi: 10.1007/s40262-023-01264-0

Antifungal dosing in critically ill patients on extracorporeal membrane oxygenation

2023

Journal Article

Is the pharmacokinetics of first-line anti-TB drugs a cause of high mortality rates in TB patients admitted to the ICU? A non-compartmental pharmacokinetic analysis

Beraldi-Magalhaes, Francisco, Parker, Suzanne L., Sanches, Cristina, Garcia, Leandro Sousa, Souza Carvalho, Brenda Karoline, Costa, Amanda Araujo, Fachi, Mariana Millan, de Liz, Marcus Vinicius, de Souza, Alexandra Brito, Safe, Izabella Picinin, Pontarolo, Roberto, Wallis, Steven, Lipman, Jeffrey, Roberts, Jason A. and Cordeiro-Santos, Marcelo (2023). Is the pharmacokinetics of first-line anti-TB drugs a cause of high mortality rates in TB patients admitted to the ICU? A non-compartmental pharmacokinetic analysis. Tropical Medicine and Infectious Disease, 8 (6) 312, 1-10. doi: 10.3390/tropicalmed8060312

Is the pharmacokinetics of first-line anti-TB drugs a cause of high mortality rates in TB patients admitted to the ICU? A non-compartmental pharmacokinetic analysis

2023

Journal Article

Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates

Collett, Simon, Earnest, Linda, Carrera Montoya, Julio, Edeling, Melissa A. A., Yap, Ashley, Wong, Chinn Yi, Christiansen, Dale, Roberts, Jason, Mumford, Jamie, Lecouturier, Valerie, Pavot, Vincent, Marco, Sergio, Loi, Joon Keit, Simmons, Cameron, Gulab, Shivali A. A., Mackenzie, Jason M. M., Elbourne, Aaron, Ramsland, Paul A. A., Cameron, Garth, Hans, Dhiraj, Godfrey, Dale I. I. and Torresi, Joseph (2023). Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates. Frontiers in Microbiology, 14 1065609, 1-22. doi: 10.3389/fmicb.2023.1065609

Development of virus-like particles with inbuilt immunostimulatory properties as vaccine candidates

2023

Journal Article

Stability of nafamostat in intravenous infusion solutions, human whole blood and extracted plasma: implications for clinical effectiveness studies

Hernández-Mitre, María Patricia, Won, Hayoung, Wallis, Steven C., Parker, Suzanne L. and Roberts, Jason A. (2023). Stability of nafamostat in intravenous infusion solutions, human whole blood and extracted plasma: implications for clinical effectiveness studies. Bioanalysis, 15 (12), 673-681. doi: 10.4155/bio-2023-0040

Stability of nafamostat in intravenous infusion solutions, human whole blood and extracted plasma: implications for clinical effectiveness studies

2023

Journal Article

A three-level model for therapeutic drug monitoring of antimicrobials at the site of infection

Brasier, Noé, Ates, H Ceren, Sempionatto, Juliane R., Cotta, Menino O., Widmer, Andreas F., Eckstein, Jens, Goldhahn, Jörg, Roberts, Jason A., Gao, Wei and Dincer, Can (2023). A three-level model for therapeutic drug monitoring of antimicrobials at the site of infection. The Lancet Infectious Diseases, 23 (10), e445-e453. doi: 10.1016/s1473-3099(23)00215-3

A three-level model for therapeutic drug monitoring of antimicrobials at the site of infection

2023

Journal Article

Ampicillin and ceftobiprole combination for the treatment of Enterococcus faecalis invasive infections: “The times they are a-changin”

Giuliano, Simone, Angelini, Jacopo, D’Elia, Denise, Geminiani, Monica, Barison, Roberto Daniele, Giacinta, Alessandro, Sartor, Assunta, Campanile, Floriana, Curcio, Francesco, Cotta, Menino Osbert, Roberts, Jason A., Baraldo, Massimo and Tascini, Carlo (2023). Ampicillin and ceftobiprole combination for the treatment of Enterococcus faecalis invasive infections: “The times they are a-changin”. Antibiotics, 12 (5) 879, 1-12. doi: 10.3390/antibiotics12050879

Ampicillin and ceftobiprole combination for the treatment of Enterococcus faecalis invasive infections: “The times they are a-changin”

2023

Journal Article

Beta-lactam dose optimisation in the intensive care unit: targets, therapeutic drug monitoring and toxicity

Legg, Amy, Carmichael, Sinead, Chai, Ming G., Roberts, Jason A. and Cotta, Menino O. (2023). Beta-lactam dose optimisation in the intensive care unit: targets, therapeutic drug monitoring and toxicity. Antibiotics, 12 (5) 870, 1-14. doi: 10.3390/antibiotics12050870

Beta-lactam dose optimisation in the intensive care unit: targets, therapeutic drug monitoring and toxicity

2023

Journal Article

Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”

Speck, Peter, Mackenzie, Jason, Bull, Rowena A., Slobedman, Barry, Drummer, Heidi, Fraser, Johanna, Herrero, Lara, Helbig, Karla, Londrigan, Sarah, Moseley, Gregory, Prow, Natalie, Hansman, Grant, Edwards, Robert, Ahlenstiel, Chantelle, Abendroth, Allison, Tscharke, David, Hobson-Peters, Jody, Kriiger-Loterio, Robson, Parry, Rhys, Marsh, Glenn, Harding, Emma, Jacques, David A., Gartner, Matthew J., Lee, Wen Shi, McAuley, Julie, Vaz, Paola, Sainsbury, Frank, Tate, Michelle D., Sinclair, Jane ... Young, Paul (2023). Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”. mSphere, 8 (3), e0016523. doi: 10.1128/msphere.00165-23

Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”

2023

Journal Article

Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”

Speck, Peter, Mackenzie, Jason, Bull, Rowena A., Slobedman, Barry, Drummer, Heidi, Fraser, Johanna, Herrero, Lara, Helbig, Karla, Londrigan, Sarah, Moseley, Gregory, Prow, Natalie, Hansman, Grant, Edwards, Robert, Ahlenstiel, Chantelle, Abendroth, Allison, Tscharke, David, Hobson-Peters, Jody, Kriiger-Loterio, Robson, Parry, Rhys, Marsh, Glenn, Harding, Emma, Jacques, David A., Gartner, Matthew J., Lee, Wen Shi, McAuley, Julie, Vaz, Paola, Sainsbury, Frank, Tate, Michelle D., Sinclair, Jane ... Young, Paul (2023). Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”. mBio, 14 (3), e0081523. doi: 10.1128/mbio.00815-23

Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”

2023

Journal Article

A systematic review on antimicrobial pharmacokinetic differences between Asian and non-Asian adult populations

Setiawan, Eko, Cotta, Menino Osbert, Roberts, Jason A. and Abdul-Aziz, Mohd Hafiz (2023). A systematic review on antimicrobial pharmacokinetic differences between Asian and non-Asian adult populations. Antibiotics, 12 (5) 803, 1-23. doi: 10.3390/antibiotics12050803

A systematic review on antimicrobial pharmacokinetic differences between Asian and non-Asian adult populations